251 related articles for article (PubMed ID: 11460409)
1. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
MMW Fortschr Med; 2001 May; 143(22):53. PubMed ID: 11460409
[No Abstract] [Full Text] [Related]
2. [Also for problem cases; successful first line therapy].
MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
[No Abstract] [Full Text] [Related]
3. [Dihydropyridines are not the only antihypertensives. Calcium blockers in the therapy of elderly hypertensive patients].
Fortschr Med Suppl; 1989; 71():1-18. PubMed ID: 2635677
[No Abstract] [Full Text] [Related]
4. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
Zanchetti A
Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
[No Abstract] [Full Text] [Related]
5. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
Christensen KL
Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
[No Abstract] [Full Text] [Related]
6. [Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
MMW Fortschr Med; 2001 Jun; 143(25):58. PubMed ID: 11469003
[No Abstract] [Full Text] [Related]
7. [Intima-media thickness in hypertensive patients. Calcium blockers controls atherosclerosis].
MMW Fortschr Med; 2002 Jan; 144(1-2):66-7. PubMed ID: 11847890
[No Abstract] [Full Text] [Related]
8. Calcium channel blocker.
Li CJ; Shi ZD
Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
[No Abstract] [Full Text] [Related]
9. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
Meier P; Burnier M
Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers. Lessons learned from MIDAS and other clinical trials.
Chobanian AV
JAMA; 1996 Sep; 276(10):829-30. PubMed ID: 8769595
[No Abstract] [Full Text] [Related]
11. [Calcium antagonists lower not only blood pressure. Arteriosclerosis is braked too].
MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759606
[No Abstract] [Full Text] [Related]
12. [[Antihypertensive therapy and organ protection].
Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
[No Abstract] [Full Text] [Related]
13. Some similarities and differences between verapamil and the dihydropyridines.
Antonios TF; MacGregor GA
J Hypertens Suppl; 1998 Jan; 16(1):S31-4. PubMed ID: 9534094
[TBL] [Abstract][Full Text] [Related]
14. [Third generation of calcium antagonists: focus on lacidipine].
Sidorenko BA; Stetsenko TM; Preobrazhenskiĭ DV; Savchenko MV; Soplevenko AV; Shabaeva EN
Kardiologiia; 2002; 42(12):81-90. PubMed ID: 12494025
[TBL] [Abstract][Full Text] [Related]
15. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
Einecke D
MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
[No Abstract] [Full Text] [Related]
16. [Calcium antagonist against hypertension. Arteriosclerosis controlled].
MMW Fortschr Med; 2002 Oct; 144(42):63. PubMed ID: 12534002
[No Abstract] [Full Text] [Related]
17. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
18. [The role of new dihydropyridine calcium channel blockers in the treatment of hypertension].
Coca A
An Med Interna; 2003 Jun; 20(6):279-81. PubMed ID: 12848596
[No Abstract] [Full Text] [Related]
19. Watanidipine. AE 0047, Calbren, GJ 0956, Vatanidipine.
Drugs R D; 2002; 3(5):331-6. PubMed ID: 12455154
[No Abstract] [Full Text] [Related]
20. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Iwasaka T
J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
